GB1119543A - Antigen preparation and vaccine - Google Patents

Antigen preparation and vaccine

Info

Publication number
GB1119543A
GB1119543A GB150466A GB150466A GB1119543A GB 1119543 A GB1119543 A GB 1119543A GB 150466 A GB150466 A GB 150466A GB 150466 A GB150466 A GB 150466A GB 1119543 A GB1119543 A GB 1119543A
Authority
GB
United Kingdom
Prior art keywords
pertussis
antigen
concentration
mixture
cell wall
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB150466A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1119543A publication Critical patent/GB1119543A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB150466A 1965-01-19 1966-01-12 Antigen preparation and vaccine Expired GB1119543A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42669165A 1965-01-19 1965-01-19

Publications (1)

Publication Number Publication Date
GB1119543A true GB1119543A (en) 1968-07-10

Family

ID=23691819

Family Applications (1)

Application Number Title Priority Date Filing Date
GB150466A Expired GB1119543A (en) 1965-01-19 1966-01-12 Antigen preparation and vaccine

Country Status (11)

Country Link
BE (1) BE675310A (enExample)
BR (1) BR6676474D0 (enExample)
DE (1) DE1617605C3 (enExample)
DK (1) DK115720B (enExample)
ES (1) ES322331A1 (enExample)
FR (2) FR1475742A (enExample)
GB (1) GB1119543A (enExample)
IL (1) IL24946A (enExample)
NL (1) NL6600703A (enExample)
NO (1) NO116869B (enExample)
SE (1) SE326797B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2845745A1 (de) * 1977-10-28 1979-05-10 American Cyanamid Co Kombinationsvaccine
EP0080021A3 (en) * 1981-11-19 1983-11-16 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338299A (en) * 1980-11-17 1982-07-06 Dso "Pharmachim" Vaccine against pertussis
CA2292462A1 (en) * 1997-06-04 1998-12-10 Kelvin Winston Duncan Method and apparatus for disruption of biological material

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2845745A1 (de) * 1977-10-28 1979-05-10 American Cyanamid Co Kombinationsvaccine
EP0080021A3 (en) * 1981-11-19 1983-11-16 American Cyanamid Company Haemophilus influenzae type b and pertussis outer membrane component combined vaccine

Also Published As

Publication number Publication date
NO116869B (enExample) 1969-06-02
DE1617605A1 (de) 1971-04-01
DK115720B (da) 1969-11-03
ES322331A1 (es) 1966-11-16
IL24946A (en) 1969-05-28
BE675310A (enExample) 1966-07-19
BR6676474D0 (pt) 1973-09-11
DE1617605B2 (de) 1974-01-31
FR1475742A (fr) 1967-04-07
SE326797B (enExample) 1970-08-03
FR5550M (enExample) 1967-11-20
NL6600703A (enExample) 1966-07-20
DE1617605C3 (de) 1974-08-29

Similar Documents

Publication Publication Date Title
Hozbor et al. Release of outer membrane vesicles from Bordetella pertussis
Levine et al. Attenuated, streptomycin-dependent Salmonella typhi oral vaccine: potential deleterious effects of lyophilization
Tacket et al. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever
Glode et al. Comparative Immunogenicity of Vaccines Prepared from Capsular Polysaccharides of Group C Neisseria meningitidis O. Acetyl. Positive and O. Acetyl. Negative Variants and Escherichia coli K92 in Adult Volunteers
Daniels et al. Characterization of the Salmonella paratyphi C Vi polysaccharide
GB1218277A (en) Dry water-dispersible aluminium hydroxide gels
GB1119543A (en) Antigen preparation and vaccine
US3395219A (en) Process for production of pertussis antigen
ES469225A1 (es) Procedimiento para potenciar la accion de las vacunas.
WO1993021951A1 (en) Method for producing a bacterial vaccine and novel vaccines produced thereby
Morris et al. The relationship of M protein and resistance to phagocytosis in the beta hemolytic streptococci
Englesberg et al. STUDIES ON IMMUNIZATION AGAINST PLAGUE VI: Growth of Pasteurella pestis and the Production of the Envelope and Other Soluble Antigens in a Casein Hydrolyzate Mineral Glucose Medium
US3465078A (en) Method of recovering antigens from bordetella pertussis cells
Lynn et al. Immunoprotective activity of ribosomes from Haemophilus influenzae
GB1441098A (en) Biological preparations
Dzata et al. Immunopotentiation of cattle vaccinated with a soluble Brucella abortus antigen with low LPS content: an analysis of cellular and humoral immune responses
US3577527A (en) Neisseria meningitidis antigen
GB1256457A (en) Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation
Chen et al. Experimental comparison of the immunogenicity of antigens in the residue of ultrasonated avirulent Pasteurella pestis with a vaccine prepared with killed virulent whole organisms
EP0004137A1 (en) Immunogenic cell envelope preparations
Landay et al. Serological comparison of the three morphological phases of Coccidioides immitis by the agar gel diffusion method
Tadayon et al. The capacity of various fractions of Pasteurella haemolytica to stimulate protective immunity in mice and hamsters
Nutter Antigens of Pasteurella tularensis: preparative procedures
IE35396L (en) Producing bruncella vaccines.
GB777018A (en) Poliomyelitis vaccine products and methods for preparing the same